Horowitz Limited Partnership Viii is > 10% Shareholder of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 1.92 Million shares of TARS, which is worth approximately $102 Million. The most recent transaction as insider was on Oct 20, 2020, when has been sold 168,750 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $2,700,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.92M
0% 3M change
0% 12M change
Total Value Held $102 Million

Horowitz Limited Partnership VIII Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2020
BUY
Open market or private purchase
$2,700,000 $16.0 p/Share
168,750 Added 8.08%
1,920,933 Common Stock
Oct 20 2020
BUY
Conversion of derivative security
-
1,752,183 Added 50.0%
1,752,183 Common Stock
HLP

Horowitz Limited Partnership Viii

> 10% Shareholder
Newport Beach, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS